Rajiv Vinnakota Biography and Net Worth

Director of Enovis

Rajiv Vinnakota has served as a director of the Company since May 13, 2008. Since July 2019, he has served as the President of the Institute for Citizens & Scholars (formerly the Woodrow Wilson National Fellowship Foundation), a 75 year-old non-profit organization that played a significant role in shaping higher education. With an expanded mission, Citizens & Scholars is now rebuilding how we develop citizens in our country. From 2015 to September 2018 he served as Executive Vice-President at the Aspen Institute, leading a division focused on youth and engagement. Prior to this role, Mr. Vinnakota was the Co-Founder and Chief Executive Officer of The SEED Foundation, a non-profit educational organization, at which he served from 1997 to 2015. Mr. Vinnakota was the chairman of The SEED Foundation board from 1997 until 2005. Prior to co-founding SEED, Mr. Vinnakota was an associate at Mercer Management Consulting. He was also a trustee of Princeton University from 2004 until 2007 and a member of the Executive Committee of the Princeton University board of directors from 2006 to 2007, and he served as the national chairman of Annual Giving at Princeton from 2007 until 2009. Mr. Vinnakota currently serves as a director of ESAB Corporation.

What is Rajiv Vinnakota's net worth?: The estimated net worth of Rajiv Vinnakota is at least $374,404.17 as of March 6th, 2024. Mr. Vinnakota owns 6,779 shares of Enovis stock worth more than $374,404 as of April 27th. This net worth approximation does not reflect any other investments that Mr. Vinnakota may own. Learn More about Rajiv Vinnakota's net worth.
How do I contact Rajiv Vinnakota?: The corporate mailing address for Mr. Vinnakota and other Enovis executives is 2711 Centerville Road Suite 400, Wilmington DE, 19808. Enovis can also be reached via phone at 302-252-9160 and via email at [email protected]. Learn More on Rajiv Vinnakota's contact information.
Has Rajiv Vinnakota been buying or selling shares of Enovis?: Rajiv Vinnakota has not been actively trading shares of Enovis during the last quarter. Most recently, Rajiv Vinnakota sold 1,396 shares of the business's stock in a transaction on Monday, May 8th. The shares were sold at an average price of $57.18, for a transaction totalling $79,823.28. Following the completion of the sale, the director now directly owns 11,901 shares of the company's stock, valued at $680,499.18. Learn More on Rajiv Vinnakota's trading history.
Who are Enovis' active insiders?: Enovis' insider roster includes Benjamin Berry (CFO), Christopher Hix (CFO), John Kleckner (Insider), Patricia Lang (SVP), A. Perfall (Director), Daniel Pryor (EVP), Brady Shirley (COO), Bradley Tandy (SVP), Matthew Trerotola (CEO), and Rajiv Vinnakota (Director). Learn More on Enovis' active insiders.
Are insiders buying or selling shares of Enovis?: During the last year, insiders at the sold shares 4 times. They sold a total of 2,282 shares worth more than $129,436.69. The most recent insider tranaction occured on August, 7th when insider John Kleckner sold 174 shares worth more than $10,297.32. Insiders at Enovis own 2.4% of the company. Learn More about insider trades at Enovis.
Information on this page was last updated on 8/7/2023.

Rajiv Vinnakota Insider Trading History at Enovis

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/8/2023	Sell	1,396	$57.18	$79,823.28	11,901

Rajiv Vinnakota Buying and Selling Activity at Enovis

Enovis Company Overview

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

Today's Range

Now: $55.23

$54.82

$55.53

50 Day Range

MA: $59.95

$55.07

$63.80

2 Week Range

Now: $55.23

$43.04

$66.14

Volume

304,173 shs

Average Volume

455,590 shs

Market Capitalization

$3.03 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.97

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>